0001214659-21-010213.txt : 20211004
0001214659-21-010213.hdr.sgml : 20211004
20211004200551
ACCESSION NUMBER: 0001214659-21-010213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211004
DATE AS OF CHANGE: 20211004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kilcoyne Adrian
CENTRAL INDEX KEY: 0001857963
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 211304743
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-53962.xml
PRIMARY DOCUMENT
X0306
4
2021-09-30
0001293310
HUMANIGEN, INC
HGEN
0001857963
Kilcoyne Adrian
C/O HUMANIGEN, INC.
533 AIRPORT BLVD., SUITE 400
BURLINGAME
CA
94010
false
true
false
false
Chief Medical Officer
Stock Option (Right to Buy)
5.93
2021-09-30
4
A
false
5863
0
A
2021-10-31
2031-09-30
Common Stock
5863
5863
D
This stock option was granted to the reporting person in lieu of 25% of his base salary for the fourth quarter of 2021. The option vests in three ratable installments on each of October 31, 2021, November 30, 2021 and December 31, 2021.
/s/ Timothy Morris, Attorney-in-Fact
2021-10-04